2026-2034年全球急性腎損傷治療市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，急性腎損傷治療市場規模將達到 34.2 億美元，高於 2025 年的 16.2 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 8.67%。

隨著醫療體係日益重視腎臟疾病的治療，全球急性腎損傷治療市場不斷成長。急性腎損傷是指腎功能迅速下降，其原因包括感染疾病、藥物或其他併發症。有效的治療對於恢復腎功能和預防長期健康問題至關重要。

多種因素正在推動急性腎損傷治療市場的成長。糖尿病和高血壓等慢性疾病的日益普及增加了腎臟併發症的風險。診斷技術的進步使得腎臟損傷的早期發現成為可能，並改善了治療效果。此外，藥物研發也不斷開發治療腎臟疾病的新方法。

隨著腎臟疾病研究的不斷深入，急性腎損傷治療市場預計將會擴大。藥物研發和治療通訊協定的改進將帶來更好的患者療效。醫療保健領域投資的增加以及人們對腎臟健康的日益關注將進一步推動市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球急性腎損傷治療市場：按類型分類

• 市場分析、洞察與預測
• 腎前性急性腎損傷
• 腎臟急性損傷
• 腎後急性腎損傷

第5章 全球急性腎損傷治療市場：依療法分類

• 市場分析、洞察與預測
• 治療方法
• 製藥

第6章：全球急性腎損傷治療市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球急性腎損傷治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Pfizer Inc
  • Roche
  • Novartis AG
  • Sanofi
  • Merck & Co.Inc
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen Inc
  • Gilead Sciences
  • Eli Lilly And Company
  • AbbVie Inc
  • Baxter International Inc
  • Fresenius Medical Care AG & Co. KGaA
  • Braun Melsungen AG
  • Asahi Kasei Medical Co.Ltd

The Acute Kidney Injury Therapeutics Market size is expected to reach USD 3.42 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 8.67% during 2026-2034.

The global acute kidney injury therapeutics market has grown as healthcare systems focus on improving treatments for kidney-related conditions. Acute kidney injury is a sudden loss of kidney function that can occur due to infections, medications, or other medical complications. Effective treatment is essential to restore kidney function and prevent long-term health problems.

Several factors are driving the growth of the acute kidney injury therapeutics market. Increasing prevalence of chronic diseases such as diabetes and hypertension has raised the risk of kidney complications. Advances in diagnostic technologies allow earlier detection of kidney injury, improving treatment outcomes. Pharmaceutical research is also developing new therapeutic approaches for kidney disease management.

In the future, the acute kidney injury therapeutics market is expected to expand as research into kidney diseases continues. Innovations in drug development and treatment protocols will improve patient outcomes. Growing healthcare investments and increased awareness of kidney health will further support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Prerenal Acute Kidney Injury
• Intrinsic Renal Acute Kidney Injury
• Postrenal Acute Kidney Injury

By Treatment

• Therapy
• Drug

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Pfizer Inc, Roche, Novartis AG, Sanofi, Merck Co, Inc, AstraZeneca, BristolMyers Squibb, Amgen Inc, Gilead Sciences, Eli Lilly and Company, AbbVie Inc, Baxter International Inc, Fresenius Medical Care AG Co KGaA, Braun Melsungen AG, Asahi Kasei Medical Co, Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ACUTE KIDNEY INJURY THERAPEUTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Prerenal Acute Kidney Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Intrinsic Renal Acute Kidney Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Postrenal Acute Kidney Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ACUTE KIDNEY INJURY THERAPEUTICS MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ACUTE KIDNEY INJURY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ACUTE KIDNEY INJURY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Treatment
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Treatment
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Treatment
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Treatment
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Treatment
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ACUTE KIDNEY INJURY THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Pfizer Inc
  • 9.2.2 Roche
  • 9.2.3 Novartis AG
  • 9.2.4 Sanofi
  • 9.2.5 Merck & Co.Inc
  • 9.2.6 AstraZeneca
  • 9.2.7 Bristol-Myers Squibb
  • 9.2.8 Amgen Inc
  • 9.2.9 Gilead Sciences
  • 9.2.10 Eli Lilly And Company
  • 9.2.11 AbbVie Inc
  • 9.2.12 Baxter International Inc
  • 9.2.13 Fresenius Medical Care AG & Co. KGaA
  • 9.2.14 Braun Melsungen AG
  • 9.2.15 Asahi Kasei Medical Co.Ltd